In conclusion, the study revealed that in HBV-associated HCC, the methylation levels of the IL-6 promoter were notably lower than those observed in patients with chronic hepatitis B. Conversely, the IL-6 mRNA levels were significantly elevated in HBV-associated HCC compared to both CHB patients and healthy individuals [63]. The gene discussed is IL6; the disease is hepatocellular carcinoma.